Takeda Pharmaceutical TAK
NYSE TAK
$18.27 -0.05 (-0.27%)
As of: Sep 9, 2026 · 2:30 PM EDT

Takeda Pharmaceutical (TAK) Prepaid Assets (2017 - 2026)

Takeda Pharmaceutical (TAK) posted Prepaid Assets of $1.2 billion for Q2 2026, up 14.2% on a QoQ basis from $1.0 billion in Q1 2026, and down 1.36% year-over-year from $1.2 billion in Q2 2025.

Analysis

Takeda Pharmaceutical (TAK) Prepaid Assets (2017 - 2026) Analysis & Trends

Takeda Pharmaceutical has reported Prepaid Assets for 10 years, with the latest figure at $1.2 billion in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 1.36% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 1.36% decrease from a year earlier, with the FY2026 full-year figure at $1.0 billion, down 1.02% from the prior year.
  • Prepaid Assets was $1.2 billion for Q2 2026 at Takeda Pharmaceutical, up from $1.0 billion in the prior quarter.
  • The five-year high for Prepaid Assets was $1.3 billion in Q2 2023, with the low at $1.0 billion in Q1 2026.
  • Average Prepaid Assets over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets gained 10.74% in 2023, then declined 12.42% in 2024.
  • Over 5 years, Prepaid Assets stood at $1.1 billion in 2022, then advanced by 10.74% to $1.2 billion in 2023, then retreated by 2.84% to $1.2 billion in 2024, then fell by 3.13% to $1.1 billion in 2025, then increased by 3.69% to $1.2 billion in 2026.
  • The last three Prepaid Assets figures came in at $1.2 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn
7 Revolution Medicines 44.12 Bn 44.12 Bn -
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn
10 Takeda Pharmaceutical 2.62 Bn -3.18 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18 Bn
Mar 31, 2026 1.04 Bn
Dec 31, 2025 1.14 Bn
Sep 30, 2025 1.13 Bn
Jun 30, 2025 1.20 Bn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 1.18 Bn
Sep 30, 2024 1.08 Bn
Jun 30, 2024 1.27 Bn
Mar 31, 2024 1.14 Bn
Dec 31, 2023 1.21 Bn
Sep 30, 2023 1.23 Bn
Jun 30, 2023 1.31 Bn
Mar 31, 2023 1.22 Bn
Dec 31, 2022 1.10 Bn
Sep 30, 2022 1.13 Bn
Jun 30, 2022 1.26 Bn
Mar 31, 2022 1.21 Bn
Dec 31, 2021 1.22 Bn
Sep 30, 2021 1.20 Bn